[National consensus of diagnosis and treatment of non-small cell lung cancer].

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 24459776
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical and Pathological Characteristics, Outcome and Mutational Profiles Regarding Non–Small-Cell Lung Cancer Related to Wood-Smoke Exposure

  2012cited by this paper
• Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.

  2012cited by this paper
• EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study.

  2012cited by this paper
• Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study.

  2012cited by this paper
• Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

  2012cited by this paper
• Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): a combined analysis of three phase 3 trials.

  2012cited by this paper
• [Personalized treatment in non-small cell lung cancer].

  2012cited by this paper
• Palliative care in lung cancer.

  2011cited by this paper
• Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214.

  2011cited by this paper
• Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study.

  2011cited by this paper
• Today's lifestyles, tomorrow's cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries.

  2011cited by this paper
• Nutritional intervention for improving treatment tolerance in cancer patients

  2011cited by this paper
• Beyond anorexia -cachexia. Nutrition and modulation of cancer patients' metabolism: supplementary, complementary or alternative anti-neoplastic therapy?

  2011cited by this paper
• Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage Classification?

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.

  2011cited by this paper
• Do patients with lung cancer benefit from physical exercise?

  2011cited by this paper
• Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy.

  2011cited by this paper
• High response of second-line chemotherapy with pemetrexed or gemcitabine combined with carboplatin in patients with non-small-cell lung cancer experiencing progression following 6 months after concluding platinum-based chemotherapy

  2011cited by this paper
• Validation of the Mexican–Spanish version of the EORTC QLQ‐C15‐PAL questionnaire for the evaluation of health‐related quality of life in patients on palliative care

  2011cited by this paper
• Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina.

  2011cited by this paper
• Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324.

  2011cited by this paper
• Increased Lung Cancer Risk among Patients with Pulmonary Tuberculosis: A Population Cohort Study

  2011cited by this paper
• Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus.

  2011cited by this paper
• Painful osseous metastases.

  2011cited by this paper
• Prognostic Impact of Number of Resected and Involved Lymph Nodes at Complete Resection on Survival in Non-small Cell Lung Cancer

  2011cited by this paper
• Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial.

  2011cited by this paper
• Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin America

  2011cited by this paper
• The management of cancer pain

  2011cited by this paper
• Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.

  2011cited by this paper
• Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.

  2011cited by this paper
• Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy

  2011cited by this paper
• Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trial.

  2011cited by this paper
• Do multidisciplinary team meetings make a difference in the management of lung cancer?

  2011cited by this paper
• Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

  2011cited by this paper
• Subclassification of Non-small Cell Lung Carcinomas Lacking Morphologic Differentiation on Biopsy Specimens: Utility of an Immunohistochemical Panel Containing TTF-1, Napsin A, p63, and CK5/6

  2011cited by this paper
• Reduced lung-cancer mortality with low-dose computed tomographic screening.

  2011cited by this paper
• Metrics to assess quality of life after management of early-stage lung cancer.

  2011cited by this paper
• Advanced Malignant Lung Disease: What the Specialist Can Offer

  2011cited by this paper
• Tubulin, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum-gemcitabine chemotherapy.

  2011cited by this paper
• Outcomes of Stereotactic Ablative Radiotherapy for Centrally Located Early-Stage Lung Cancer

  2011cited by this paper
• Lean body mass gain in patients with head and neck squamous cell cancer treated perioperatively with a protein‐ and energy‐dense nutritional supplement containing eicosapentaenoic acid

  2011cited by this paper
• Safety and utility of mediastinoscopy in non-small cell lung cancer in a complex mediastinum.

  2011cited by this paper
• Exercise intervention to improve exercise capacity and health related quality of life for patients with Non-small cell lung cancer: a systematic review.

  2011cited by this paper
• Role of surgery following induction therapy for stage III non-small cell lung cancer.

  2011cited by this paper
• Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.

  2011cited by this paper
• Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer.

  2011cited by this paper
• Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial.

  2010cited by this paper
• Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab.

  2010cited by this paper
• Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment.

  2010cited by this paper
• Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer.

  2010cited by this paper
• The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design

  2010cited by this paper
• Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.

  2010cited by this paper
• Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples

  2010cited by this paper
• A randomized phase III study of the docetaxel/carboplatin combination versus docetaxel single-agent as second line treatment for patients with advanced/metastatic Non-Small Cell Lung Cancer

  2010cited by this paper
• Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

  2010cited by this paper
• Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR.

  2010cited by this paper
• Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099.

  2010cited by this paper
• A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors

  2010cited by this paper
• Randomized phase III trial of platinum-doublet chemotherapy followed by gefitinib compared with continued platinum-doublet chemotherapy in Japanese patients with advanced non-small-cell lung cancer: results of a west Japan thoracic oncology group trial (WJTOG0203).

  2010cited by this paper
• Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials

  2010cited by this paper
• In-patient rehabilitation of lung cancer patients—a prospective study

  2010cited by this paper
• Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer.

  2010cited by this paper
• Endobronchial ultrasound‐guided transbronchial needle aspiration cytology: a state of the art review

  2010cited by this paper
• Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

  2010cited by this paper
• Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy

  2010cited by this paper
• Screening for Lung Cancer with Low-Dose Computed Tomography: A Systematic Review and Meta-Analysis of the Baseline Findings of Randomized Controlled Trials

  2010cited by this paper
• Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: An international individual patient data meta-analysis.

  2010cited by this paper
• Significance of thymidylate synthase for resistance to pemetrexed in lung cancer

  2010cited by this paper
• Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma.

  2010cited by this paper
• Glutamine as indispensable nutrient in oncology: experimental and clinical evidence

  2010cited by this paper
• Is the WHO analgesic ladder still valid? Twenty-four years of experience.

  2010cited by this paper
• Treatment of Cachexia in Oncology

  2010cited by this paper
• Exercise interventions following surgery for non-small cell lung cancer (NSCLC): the need for future randomised controlled trials.

  2010cited by this paper
• Evaluation of tumor position and PTV margins using image guidance and respiratory gating.

  2010cited by this paper
• Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.

  2010cited by this paper
• Fatigue and functional impairment in early-stage non-small cell lung cancer survivors.

  2010cited by this paper
• Required area of lymph node sampling during segmentectomy for clinical stage IA non-small cell lung cancer.

  2010cited by this paper
• Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.

  2010cited by this paper
• Stereotactic body radiation therapy for inoperable early stage lung cancer.

  2010cited by this paper
• Cardiopulmonary exercise testing in the evaluation of high risk patients with lung cancer.

  2010cited by this paper
• The effect of in-patient chest physiotherapy in lung cancer patients

  2010cited by this paper
• Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study

  2010cited by this paper
• Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial.

  2010cited by this paper
• Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

  2010cited by this paper
• An Update on Lung Cancer Staging

  2010cited by this paper
• Early palliative care for patients with metastatic non-small-cell lung cancer.

  2010cited by this paper
• Pre-operative pulmonary evaluation of lung cancer patients: a review of the literature

  2009cited by this paper
• A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation.

  2009cited by this paper
• The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer

  2009cited by this paper
• Improving cancer outcomes through international collaboration in academic cancer treatment trials.

  2009cited by this paper
• Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.

  2009cited by this paper
• Cough in the palliative care setting.

  2009cited by this paper
• Management of lung nodules detected by volume CT scanning.

  2009cited by this paper
• Rehabilitation in the Intensive Care Unit

  2009cited by this paper
• [Prolonged exposure to atmospheric air pollution and mortality from respiratory causes].

  2009cited by this paper
• A Phase II Study of Concurrent Chemoradiation with Weekly Docetaxel, Carboplatin, and Radiation Therapy Followed by Consolidation Chemotherapy with Docetaxel and Carboplatin for Locally Advanced Inoperable Non-small Cell Lung Cancer (NSCLC)

  2009cited by this paper
• Indoor air pollution as a lung health hazard: focus on populous countries

  2009cited by this paper
• A Structured Exercise Program for Patients with Advanced Non-small Cell Lung Cancer

  2009cited by this paper
• A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515.

  2009cited by this paper

• Early Incorporation to Palliative Care (EPC) in Patients With Advanced Non-Small Cell Lung Cancer: The PACO Randomized Clinical Trial

  2024cites this paper
• Estimation of the Clinical, Economic, and Social Burden of Stage IV Non-Small Cell Lung Cancer in Mexico

  2024cites this paper
• DTPA clearance test: a sensitive method for detecting radiation-induced lung fibrosis in lung cancer patients

  2023cites this paper
• Consideration of lung dose changes when establishing lung cancer treatment plans according to tumor changes

  2023cites this paper
• Association of BMI With Benefit of Metformin Plus Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients With Advanced Lung Adenocarcinoma: A Secondary Analysis of a Phase 2 Randomized Clinical Trial.

  2022cites this paper
• Clinical and pathological characteristics associated with the presence of the IS6110 Mycobacterim tuberculosis transposon in neoplastic cells from non-small cell lung cancer patients

  2022cites this paper
• Radiation-induced lung injury: current evidence

  2021cites this paper
• Human skin biomarkers relationship to response to treatment with tyrosine kinase inhibitors in advanced EGFR‐mutated lung adenocarcinoma

  2020cites this paper
• Baseline Dysgeusia in Chemotherapy-Naïve Non-Small Cell Lung Cancer Patients: Association with Nutrition and Quality of Life

  2020cites this paper
• Response rate of patients with baseline brain metastases from recently diagnosed non‐small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation status

  2020cites this paper
• Effectiveness of Diagnostic Tools and Management of Lung Cancer

  2020cites this paper
• Establishment and Validation of Nomogram Model Integrated With Inflammation-Based Factors for the Prognosis of Advanced Non-Small Cell Lung Cancer

  2020cites this paper
• Integrated analysis of long non-coding RNAs and mRNA profiles reveals potential sex-dependent biomarkers of bevacizumab/erlotinib response in advanced lung cancer

  2020cites this paper
• Radical consolidative treatment provides a clinical benefit and long-term survival in patients with synchronous oligometastatic non-small cell lung cancer: A phase II study.

  2019cites this paper
• CD146 T cells in lung cancer: its function, detection, and clinical implications as a biomarker and therapeutic target

  2019cites this paper
• Treatment Patterns and Costs Associated with Stage IV Non-Small Cell Lung Cancer in a Mexican Population: A Chart Review

  2019cites this paper
• EGFR exon 20 insertion in lung adenocarcinomas among Hispanics (geno1.2-CLICaP).

  2018cites this paper
• A novel biomarker protein panel for lung cancer, a promising first step.

  2018cites this paper
• Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology Practices

  2018cites this paper
• The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial

  2018cites this paper
• The reality of complexity: concomitant genomic alterations in patients with EGFR mutations.

  2018cites this paper
• Extending the curve: survival of EGFR-mutated lung cancer patients in the 21st century.

  2018cites this paper
• Characteristics of progression to tyrosine kinase inhibitors predict overall survival in patients with advanced non-small cell lung cancer harboring an EGFR mutation.

  2018cites this paper
• Longitudinal Evaluation of Lung Function in Patients With Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiation Therapy.

  2018cites this paper
• Targeted next generation sequencing identified a high frequency genetic mutated profile in wood smoke exposure-related lung adenocarcinoma patients

  2018cites this paper
• FAACT-Anorexia Cachexia Scale: Cutoff Value for Anorexia Diagnosis in Advanced Non-Small Cell Lung Cancer Patients

  2018cites this paper
• Molecular Epidemiology of ALK Rearrangements in Advanced Lung Adenocarcinoma in Latin America

  2018cites this paper
• All-trans retinoic acid in combination with cisplatin and paclitaxel enhances apoptosis and upregulates retinoic acid receptors in lung adenocarcinoma cells

  2017cites this paper
• CD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients

  2017cites this paper
• Lung Cancer in Northeastern Mexico: Epidemiology and Molecular Markers

  2017cites this paper
• Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients

  2017cites this paper
• Reproducibility of the EGFR immunohistochemistry scores for tumor samples from patients with advanced non-small cell lung cancer.

  2017cites this paper
• Diagnosis of EML4-ALK Translocation With FISH, Immunohistochemistry, and Real-time Polymerase Chain Reaction in Patients With Non–Small Cell Lung Cancer

  2017cites this paper
• Ramucirumab in the treatment of non-small cell lung cancer

  2017cites this paper
• Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients

  2017cites this paper
• Survival of Patients with Advanced Non-Small Cell Lung Cancer Enrolled in Clinical Trials

  2016cites this paper
• Value: Changes in the Detection and Recognition Thresholds of Three Basic Tastes in Lung Cancer Patients Receiving Cisplatin and Paclitaxel and Its Association with Nutritional and Quality of Life Parameters

  2016cites this paper
• Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer

  2016cites this paper
• Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer

  2016cites this paper
• Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial

  2016cites this paper
• Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer

  2016cites this paper
• The safety of afatinib for the treatment of non-small cell lung cancer

  2016cites this paper
• Proposals for the prevention of lung cancer in the health system of Mexico.

  2016cites this paper
• Gene-expression profiles in lung adenocarcinomas related to chronic wood smoke or tobacco exposure

  2016cites this paper
• Different mutation profiles and clinical characteristics among Hispanic patients with non-small cell lung cancer could explain the "Hispanic paradox".

  2015cites this paper
• Outcome of Patients with Lung Adenocarcinoma Harboring Common and Rare Epidermal Growth Factor Receptor Mutations in Response to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

  2015cites this paper
• The impact of common and rare EGFR mutations in response to EGFR tyrosine kinase inhibitors and platinum-based chemotherapy in patients with non-small cell lung cancer.

  2015cites this paper
• Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)

  2015influential citation
• Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.

  2015cites this paper
• Medical care costs incurred by patients with smoking-related non-small cell lung cancer treated at the National Cancer Institute of Mexico

  2015cites this paper
• Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients.

  2015cites this paper
• Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer.

  2014cites this paper
• [Science and confidence: the need to be clear- reply].

  2014cites this paper
• Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease

  2014cites this paper
• Molecular detection and prognostic value of epithelial markers mRNA expression in peripheral blood of advanced non-small cell lung cancer patients

  2014cites this paper
• Long progression-free survival with first-line paclitaxel plus platinum is associated with improved response and progression-free survival with second-line docetaxel in advanced non-small-cell lung cancer

  2014cites this paper